Author Archives: juliepapet

Career Chat on 12th of September at 18:00 at Irchel Campus Y03-G85 and online – organized by LSZYSN

Posted on by

Five panelists will discuss about opportunities, challenges and experiences in life science startups:

  • Martyna Wroblewska, Manager Innovation and Sourcing at BaseLaunch
  • Dr. Simon Bredl, Founder of Trojan Therapeutics
  • Dr. Gabriel Leventhal, CSO of PharmaBiome
  • Dr. Joshua Jordi, CEO of EraCal
  • Dr. Christian Jost, Co-Founder and VP Early Partnering of Athebio

Don’t miss this opportunity to get first-hand insights into life science startups and get to know the speakers at the apéro after!

Registration via: careerchat.lszysn.ch

Martyna Wroblewska is a Manager of Innovation & Sourcing at BaseLaunch accelerator. BaseLaunch works with scientists and entrepreneurs and helps them build exceptional biotech ventures from scratch, by providing convertible loan financing, access to partners (Roche, J&J, CSL Behring, CMS, Roivant Sciences, BridgeBio, and Pureos Bioventures), and drug development expertise. She studied at the University of Zurich, and before joining BaseLaunch in 2021 worked for a Zurich-based biotech start-up as a Project Leader, where she was responsible for the design, development, and management of projects focused on oncology and vaccine development.

Simon Bredl is in the process of translating his cell based immunotherapy into the startup Trojan Therapeutics. Simon has a background in immunology, virology and molecular biology, with an interest in synthetic biology. After his Postdoc, he worked as a scientist for Redbiotec AG in Schlieren and was part of their success story. At the moment, Simon is working on monocyte-based immunotherapy, comparable to CAR T-cell therapy, for immunological cold, solid tumors.

Gabriel Leventhal is the Chief Scientific Officer of PharmaBiome, an ETH spin-off that is developing multi-strain bacterial consortia to treat diseases linked to the gut microbiome. Gabriel is originally a physicist and a mathematical biologist by training, but has been working in microbial ecology for the last 10 years. Following a postdoc at MIT, he returned to Switzerland to join PharmaBiome and push their mission of developing targeted microbiome live biotherapeutic consortium products.

Joshua Jordi has led EraCal as CEO since its inception. He is a biochemist from ETH by training and completed his PhD in physiology at UZH. Joshua invented EraCal’s foundational platform technology as a postdoctoral fellow at Harvard University. EraCal was founded as a UZH and Harvard University spin-off in 2018 and aims to fight excess weight and obesity as the most widespread health risk globally by developing a novel drug candidate to reduce appetite.

Christian Jost is the co-founder of Athebio and studied DARPins and their biotechnological potential for nearly 10 years in an academic setting. He then extended his knowledge towards pharmaceutical drug development and became a Senior Scientist at Roche-Glycart. With his expertise from both academia and industry, Christian connects the biological ideas and needs of their Pharma partners with the possibilities of Athebio’s Athebody® DARPIn technology.

Farewell Thomas, Justine and Enrico!

Posted on by

We bid farewell to Dr. Thomas Auer and his lab members, Justine Pascual and Enrico Bertolini, who have moved to the Department of Biology at the University of Fribourg on September 1st.

We wish them all the best in their new group at the University of Fribourg!

Next CIG Pogress report seminars is a FLASH-talk session!

Posted on by

 The 1st session of the seminar series is Thursday Oct 5th 16-17h in GEN-B 

FLASH! 
All new comers to CIG since Nov 2022 present themselves in 1 slide in 1 minute:
Where are you coming from? What is your expertise? What will you be working on? Is there a fun fact about you that few people know? Feel free to use your imagination to make a personalized and brief introduction of yourself to the CIG.
More information will follow by email.
Questions can be addressed to Prof. Aleksandar Vjestica and Prof. Maria Cristina Gambetta.

InnoPACTT: a financial support to create your start-up – AUTUMN CALL, Deadline Oct. 2, 2023

Posted on by

You are a UNIL-CHUV researcher who would like to create a start-up and need a
financial support to start?

Apply for a one-year InnoTREK grant to launch your UNIL-CHUV spin-off !

PACTT, the Technology Transfer Office of UNIL-CHUV, is calling for start-up projects in order to award the InnoTREK grant. As part of the InnoPACTT financial support, the InnoTREK grant is designed to accelerate innovation and UNIL-CHUV spin-off creation, and to encourage researchers with innovative ideas to jump into the entrepreneurship adventure.

Deadline for submission: October 2, 2023
For conditions, registration form and information:

For conditions, registration form and information: www.pactt.ch/innotrek/

Contact:
innopactt.info@chuv.ch
Tel: 021 314 39 84
021 314 82 19
079 556 20 60

Rigi Workshop 2024: Exploring Epigenetics, Jan. 28-30, 2024 – Deadline Sep. 30, 2023

Posted on by

Interdisciplinary insights beyond DNA sequence, at the Hotel Rigi Kulm, Schwyz (CH).

PhD Students and Post-Docs: Join us from 28 to 30 January 2024 at the beautiful Hotel Rigi Kulm in Schwyz (CH) for a 3-days interdisciplinary workshop to explore Epigenetics. Application to participate is open until 30 September 2023.

Rigi Workshop 2024 - Cover

Epigenetics is a broadly used term for phenomena that alter gene expression without altering the DNA itself. It describes the regulation of our genes, how they can be influenced by our environment, and how this regulation can be inherited between cells and generations. This intersection between information coded in DNA sequence, transmitted by factors associated with DNA, and provided by the environment is fascinating from a mechanistic point of view. It also provides insights into how our genes interact with external influences, potentially offering new ways to prevent or treat diseases, improve crop yields, and understand complex behaviors and brain functions.

The Rigi workshop 2024 on epigenetics invites its participants to dive into the intricate mechanisms and implications of epigenetic phenomena. By fostering cross-disciplinary dialogue, the event aims to bridge gaps between different disciplines of epigenetic research. Participants will explore how epigenetics impacts plant breeding, behavioral traits, brain development, evolution, synaptic plasticity, cognition, and neurological disorders. The workshop will offer interdisciplinary approaches to investigating and analyzing societal and technological impacts of epigenetics and will feature lectures delivered by leading experts, group discussions, and sharing of group and individual work in the form of poster and oral presentations.

Registration and information: https://scnat.ch/fr/uuid/i/70087125-1b58-500a-bcb3-298c4a25b377-Rigi_Workshop_2024_Exploring_Epigenetics